CTI BioPharma
CTIC
#5850
Rank
A$1.70 B
Marketcap
A$12.92
Share price
0.00%
Change (1 day)
20.99%
Change (1 year)

CTI BioPharma (CTIC) - Total liabilities

Total liabilities on the balance sheet as of March 2023 : A$0.19 Billion

According to CTI BioPharma 's latest financial reports the company's total liabilities are A$0.19 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

CTI BioPharma - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$0.21 B122.64%
2021-12-31A$94.71 M299.9%
2020-12-31A$23.68 M-41.51%
2019-12-31A$40.49 M-22.68%
2018-12-31A$52.36 M5.38%
2017-12-31A$49.69 M-36.13%
2016-12-31A$77.8 M-41.52%
2015-12-31A$0.13 B102.35%
2014-12-31A$65.74 M15.07%
2013-12-31A$57.13 M45.64%
2012-12-31A$39.23 M17.52%
2011-12-31A$33.38 M-42.27%
2010-12-31A$57.82 M-41.22%
2009-12-31A$98.36 M-63.07%
2008-12-31A$0.26 B28.36%
2007-12-31A$0.20 B-19.6%
2006-12-31A$0.25 B-28.08%
2005-12-31A$0.35 B8.59%
2004-12-31A$0.33 B7.43%
2003-12-31A$0.30 B20.94%
2002-12-31A$0.25 B-33.16%
2001-12-31A$0.38 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
A$113.16 B 57,744.48%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
A$121.37 B 61,939.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$118.43 B 60,439.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A$19.66 B 9,949.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
A$2.43 B 1,147.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$94.35 B 48,130.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$45.21 B 23,013.09%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel